메뉴 건너뛰기




Volumn 28, Issue 3, 2008, Pages 276-283

Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia

Author keywords

DLI; Donor lymphocyte infusion; GVHD; Haploidentical; HLA mismatched; HSCT; Relapse; Transplantation

Indexed keywords

AZATHIOPRINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DACLIZUMAB; FLUDARABINE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SEMUSTINE; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY;

EID: 43049141466     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-007-9166-z     Document Type: Article
Times cited : (56)

References (26)
  • 1
    • 0036196228 scopus 로고    scopus 로고
    • The search for optimal treatment in relapsed and refractory acute myeloid leukemia
    • Robak T, Wrzesien-Kus A. The search for optimal treatment in relapsed and refractory acute myeloid leukemia. Leuk Lymphoma 2002;43:281-91.
    • (2002) Leuk Lymphoma , vol.43 , pp. 281-291
    • Robak, T.1    Wrzesien-Kus, A.2
  • 2
    • 0033665538 scopus 로고    scopus 로고
    • Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: A retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM)
    • Michallet M, Thomas X, Vernant JP, et al. Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM). Bone Marrow Transplant 2000;26:1157-63.
    • (2000) Bone Marrow Transplant , vol.26 , pp. 1157-1163
    • Michallet, M.1    Thomas, X.2    Vernant, J.P.3
  • 3
    • 0029868846 scopus 로고    scopus 로고
    • Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation
    • Slavin S, Naparstek E, Nagler A. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996;87:2195-204.
    • (1996) Blood , vol.87 , pp. 2195-2204
    • Slavin, S.1    Naparstek, E.2    Nagler, A.3
  • 4
    • 0037496010 scopus 로고    scopus 로고
    • An improved anti-leukemic effect achieved with donor progenitor cell infusion for relapse patients after allogeneic bone marrow transplantation
    • Huang XJ, Guo NL, Ren HY, Xu LP, Chen H, Liu KY, et al. An improved anti-leukemic effect achieved with donor progenitor cell infusion for relapse patients after allogeneic bone marrow transplantation. Chinese Med J 2003;116:736-41.
    • (2003) Chinese Med J , vol.116 , pp. 736-741
    • Huang, X.J.1    Guo, N.L.2    Ren, H.Y.3    Xu, L.P.4    Chen, H.5    Liu, K.Y.6
  • 5
    • 31444434598 scopus 로고    scopus 로고
    • Prophylactic infusion of donor granulocyte colony stimulating factor mobilized peripheral blood progenitor cells after allogeneic hematological stem cell transplantation in patients with high-risk leukemia
    • Huang XJ, Liu DH, Xu LP, Chen H, Liu KY, Han W, et al. Prophylactic infusion of donor granulocyte colony stimulating factor mobilized peripheral blood progenitor cells after allogeneic hematological stem cell transplantation in patients with high-risk leukemia. Leukemia 2006;20:365-8.
    • (2006) Leukemia , vol.20 , pp. 365-368
    • Huang, X.J.1    Liu, D.H.2    Xu, L.P.3    Chen, H.4    Liu, K.Y.5    Han, W.6
  • 6
    • 17744370942 scopus 로고    scopus 로고
    • Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: High remission rate among poor prognosis patients at the expense of graft-versus-host disease
    • De Lima M, Bonamino M, Vasconcelos Z, et al. Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease. Bone Marrow Transplant 2001;27:73-8.
    • (2001) Bone Marrow Transplant , vol.27 , pp. 73-78
    • De Lima, M.1    Bonamino, M.2    Vasconcelos, Z.3
  • 7
    • 34247602156 scopus 로고    scopus 로고
    • Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation
    • Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W. Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation. Haematologica 2007;92:414-7.
    • (2007) Haematologica , vol.92 , pp. 414-417
    • Huang, X.J.1    Liu, D.H.2    Liu, K.Y.3    Xu, L.P.4    Chen, H.5    Han, W.6
  • 8
    • 0036156857 scopus 로고    scopus 로고
    • Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia
    • Mengarelli A, Iori A, Guglielmi C, et al. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Haematologica 2002;87:52-8.
    • (2002) Haematologica , vol.87 , pp. 52-58
    • Mengarelli, A.1    Iori, A.2    Guglielmi, C.3
  • 9
    • 0035068944 scopus 로고    scopus 로고
    • Who should be transplanted for AML
    • Appelbaum FR. Who should be transplanted for AML. Leukemia 2001;15:680-2.
    • (2001) Leukemia , vol.15 , pp. 680-682
    • Appelbaum, F.R.1
  • 10
    • 33746936705 scopus 로고    scopus 로고
    • Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of hematological malignancies
    • Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 2006;38:291-7.
    • (2006) Bone Marrow Transplant , vol.38 , pp. 291-297
    • Huang, X.J.1    Liu, D.H.2    Liu, K.Y.3    Xu, L.P.4    Chen, H.5    Han, W.6
  • 11
    • 11344260431 scopus 로고    scopus 로고
    • Standardization and quality control in flow cytometric enumeration of CD34(+) cells
    • Liu Y, Chen S, Yu H. Standardization and quality control in flow cytometric enumeration of CD34(+) cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2000;8:302-6.
    • (2000) Zhongguo Shi Yan Xue Ye Xue Za Zhi , vol.8 , pp. 302-306
    • Liu, Y.1    Chen, S.2    Yu, H.3
  • 14
    • 85047699216 scopus 로고    scopus 로고
    • Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia
    • Singhal S, Powles R, Henslee-Downey PJ, et al. Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia. Bone Marrow Transplant 2002;29:291-5.
    • (2002) Bone Marrow Transplant , vol.29 , pp. 291-295
    • Singhal, S.1    Powles, R.2    Henslee-Downey, P.J.3
  • 15
    • 0034672269 scopus 로고    scopus 로고
    • Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group Study
    • Slovak ML, Kopecky KJ, Cassileth PA, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000;96:4075-83.
    • (2000) Blood , vol.96 , pp. 4075-4083
    • Slovak, M.L.1    Kopecky, K.J.2    Cassileth, P.A.3
  • 16
    • 0034009065 scopus 로고    scopus 로고
    • Treatment of relapsed and refractory acute myeloid leukemia
    • Estey EH. Treatment of relapsed and refractory acute myeloid leukemia. Leukemia 2000;14:476-9.
    • (2000) Leukemia , vol.14 , pp. 476-479
    • Estey, E.H.1
  • 17
    • 0027073173 scopus 로고
    • Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia
    • Clift RA, Buckner CD, Appelbaum FR, et al. Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. J Clin Oncol 1992;10:1723-9.
    • (1992) J Clin Oncol , vol.10 , pp. 1723-1729
    • Clift, R.A.1    Buckner, C.D.2    Appelbaum, F.R.3
  • 18
    • 33746607667 scopus 로고    scopus 로고
    • Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
    • Christoph S, Michael S, Rainer S, et al. Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. Blood 2006;108:1092-9.
    • (2006) Blood , vol.108 , pp. 1092-1099
    • Christoph, S.1    Michael, S.2    Rainer, S.3
  • 19
    • 0033028697 scopus 로고    scopus 로고
    • Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation
    • Alessandrino EP, Bernasconi P, Caldera D. Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999;23:607-12.
    • (1999) Bone Marrow Transplant , vol.23 , pp. 607-612
    • Alessandrino, E.P.1    Bernasconi, P.2    Caldera, D.3
  • 20
    • 1442286015 scopus 로고    scopus 로고
    • Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect
    • Chen SH, Li X, Huang XJ. Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect. Int J Hematol 2004;79:178-84.
    • (2004) Int J Hematol , vol.79 , pp. 178-184
    • Chen, S.H.1    Li, X.2    Huang, X.J.3
  • 21
    • 10444239214 scopus 로고    scopus 로고
    • In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor
    • Huang XJ, Chang YJ, Zhao XY. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Haematologica 2004;89:1517-24.
    • (2004) Haematologica , vol.89 , pp. 1517-1524
    • Huang, X.J.1    Chang, Y.J.2    Zhao, X.Y.3
  • 22
    • 20344396399 scopus 로고    scopus 로고
    • A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts
    • Huang XJ, Chang YJ, Zhao XY. A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts. Haematologica 2005;90:715-6.
    • (2005) Haematologica , vol.90 , pp. 715-716
    • Huang, X.J.1    Chang, Y.J.2    Zhao, X.Y.3
  • 23
    • 33847222758 scopus 로고    scopus 로고
    • Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions
    • Huang XJ, Chang YJ, Zhao XY. Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions. Transplant Immunol 2007;17:193-7.
    • (2007) Transplant Immunol , vol.17 , pp. 193-197
    • Huang, X.J.1    Chang, Y.J.2    Zhao, X.Y.3
  • 24
    • 0036142202 scopus 로고    scopus 로고
    • Prophylactic growth factor-mobilized donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies
    • Sohn SK, Jung JT, Kim DH, Lee NY, Seo KW, Chae YS, et al. Prophylactic growth factor-mobilized donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies. Cancer 2002;94:18-24.
    • (2002) Cancer , vol.94 , pp. 18-24
    • Sohn, S.K.1    Jung, J.T.2    Kim, D.H.3    Lee, N.Y.4    Seo, K.W.5    Chae, Y.S.6
  • 25
    • 27844476033 scopus 로고    scopus 로고
    • Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: Significant roles of total body irradiation and chronic graft-versus-host disease
    • Yanada M, Naoe T, Iida H. Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease. Bone Marrow Transplant 2005;36:867-72.
    • (2005) Bone Marrow Transplant , vol.36 , pp. 867-872
    • Yanada, M.1    Naoe, T.2    Iida, H.3
  • 26
    • 0034794596 scopus 로고    scopus 로고
    • Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan
    • Ko BS, Tang JL, Tsai W. Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan. Ann Hematol 2001;80:510-5.
    • (2001) Ann Hematol , vol.80 , pp. 510-515
    • Ko, B.S.1    Tang, J.L.2    Tsai, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.